Home/Pipeline/Obesity Clinical Trials

Obesity Clinical Trials

Obesity

Not Applicable (Service)Active

Key Facts

Indication

Obesity

Phase

Not Applicable (Service)

Status

Active

Company

IMA Clinical Research

About IMA Clinical Research

IMA Clinical Research is a private, revenue-generating clinical research services company with a nationwide network of over 15 full-service sites and 150+ satellite locations. Its business model is centered on providing clinical trial execution services to pharmaceutical sponsors and CROs, leveraging a large patient database and a flexible, decentralized operational model to accelerate enrollment. The company is actively recruiting for trials in key therapeutic areas including metabolic-liver disease (MASH), neurology (memory loss), psychiatry (depression), and obesity, indicating a focus on high-prevalence chronic conditions.

View full company profile

Therapeutic Areas

Metabolic Disease (MASH)Neurology (Memory Loss)Psychiatry (Depression)Obesity

Other Obesity Drugs

Drug	Company	Phase	Status
LET003	Harbour BioMed	Discovery	Active (Global)
LET001	Harbour BioMed	Discovery	Active (Global)
RGT-075	Regor Therapeutics	Phase 2b	Active
Anti‑Obesity Oral Drug	Premas Biotech	Phase 1	Active
Obesity Target Discovery Collaboration	Fauna Bio	Target Discovery/Preclinical	Active
GLP-1 variants	Heligenics	Discovery	Active
MYO Platform (Metabolic Disease)	Renbio	Pre-clinical	Active
KAYO-2000	KayoThera	Preclinical	Active
MVD-1 (SANA)	Eolo Pharma	Phase 1	Active
GIP-neutralizing antibody	Helicore Biopharma	Pre-clinical	Active
Antral Gastroplasty / Endoscopic Sleeve	Endo-TAGSS	Pre-clinical	Active
Undisclosed siRNA Programs	Moonwalk Biosciences	Pre-clinical	Active